| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. | Chief Medical Officer | Common Stock | 183,914 | $739,334 | $4.02 | 06 Feb 2026 | Direct |
| Voyager Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 210,000 | 06 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 06 Feb 2026 | 2 | $0 | 4 | Chief Medical Officer | 10 Feb 2026, 16:33 |
| VYGR | Voyager Therapeutics, Inc. | 18 Aug 2025 | 1 | -$70,870 | 4 | Chief Medical Officer | 20 Aug 2025, 14:09 |
| VYGR | Voyager Therapeutics, Inc. | 02 Apr 2025 | 1 | -$34,595 | 4 | Chief Medical Officer | 04 Apr 2025, 16:10 |
| VYGR | Voyager Therapeutics, Inc. | 21 Feb 2025 | 2 | $0 | 4 | Chief Medical Officer | 24 Feb 2025, 16:16 |
| VYGR | Voyager Therapeutics, Inc. | 01 Apr 2024 | 1 | $0 | 4 | Chief Medical Officer | 03 Apr 2024, 16:17 |
| VYGR | Voyager Therapeutics, Inc. | 25 Mar 2024 | 1 | $0 | 4 | Chief Medical Officer | 26 Mar 2024, 17:27 |
| VYGR | Voyager Therapeutics, Inc. | 25 Mar 2024 | 0 | $0 | 3 | Chief Medical Officer | 26 Mar 2024, 17:24 |